U.S. Cardiac Ablation Market - Databook 2025 to 2034

The U.S. cardiac ablation market size was calculated at USD 1.89 billion in 2024 and is predicted to attain around USD 5.97 billion by 2034, expanding at a CAGR of 12.18% from 2025 to 2034.

Highlights of the U.S. Cardiac Ablation Market

• By product, the electrical ablators segment held a dominant presence in the market in 2024.
• By product, the segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By approach, the catheter-based segment captured a significant portion of the market in 2024.
• By approach, the open/surgical segment is projected to expand rapidly in the market in the coming years.
• By application, the atrial fibrillation & flutter segment enjoyed a prominent position in the market during 2024.
• By application, the tachycardia segment will gain a significant share of the market over the studied period of 2025 to 2034.
• By end use, the ambulatory surgical centers segment registered its dominance over the market in 2024.
• By end use, the segment is anticipated to grow with the highest CAGR in the market during the studied years.

Industry Valuation and Growth Rate Projection

The U.S. cardiac ablation market is seeing rapid growth due to the increasing rate of heart rhythm issues, including atrial fibrillation. Cardiac ablation is a treatment to eliminate part of the heart that is causing irregular rhythm, using thermal or cold energy. Cardiac ablation is often desired by patients, more available to patients, and less invasive than open-heart surgery, so physicians and hospitals are opting for this less invasive treatment. New technology, increasing tools available for physicians to incorporate into clinical practice, and large company support to market the treatment are all magnifying the growth of the U.S. cardiac ablation market. A large cohort of patients requiring cardiac ablation is the retiring baby boomers.

Several patients have indicated their health insurance plans cover the costs associated with these minimally invasive treatments. Some of the largest health companies are actively seeking research opportunities within cardiac ablation to create new technology that allows for quicker and more accurate processes to be developed and tested. My thought is that with increased awareness, more resources, company research, and the U.S. patient market demands, healthy growth can be expected within the U.S. cardiac ablation market in the coming years.

What are the Market Trends in the Cardiac Ablation Market?

• Market trends in the U.S. cardiac ablation market center around an increase in heart rhythm disorders and a switch among healthcare providers to invasive procedures.
• Increase in atrial fibrillation: An increasing number of individuals in the U.S., mainly older adults, are being diagnosed with atrial fibrillation, which has translated into higher demand for ablation therapy.
• Trend towards minimally invasive procedures: Ablation is favored over open-heart surgery by both physicians and patients because of the safer and quicker recovery.
• High hospital utilization: Hospitals across the U.S. have become more committed to investing in ablation technology, improving heart care services.
• Integration of AI and robotics: Artificial intelligence and robotic systems are utilized at a few centers to provide more accuracy in cardiac ablation.

What are the Restraints in the Cardiac Ablation Market?

• There are restraints in the American cardiac ablation market, including a lack of properly trained healthcare providers, along with restrictive FDA regulations.
• High cost of procedure and devices: Heart ablation and the instruments used can lead to a fairly expensive treatment that may not easily be available to patients without strong insurance.
• Limited trained professionals: There are not trained electrophysiologists in every area in the U.S. to safely and effectively perform ablation.
• Rigid FDA regulations: New ablation products require rigorous approval processes, which can delay market growth.

What are the Opportunities in the U.S. Cardiac Ablation Market?

• There are multiple opportunities in the U.S. cardiac ablation market due to the large-scale implementation of telehealth services and a rise in subsidised outpatient clinics.
• Expanding telehealth services: Remote monitoring and follow-up virtual care on cardiac ablation can be more useful and user-friendly.
• Government incentives for heart health: US health agencies are funding initiatives and research to directly fight heart disease and discover new preventative measures.
• Rise of outpatient clinics: More specialized heart clinics and ambulatory clinics are able to provide access to the ablation procedure and help many more patients quickly.

Recent Developments in the U.S. Cardiac Ablation Market:

• In June 2025, Johnson & Johnson (J&J) MedTech announced the launch of the Soundstar Crystal ultrasound catheter for intracardiac echocardiography (ICE) imaging in cardiac ablation procedures in the United States. This catheter is J&J’s latest addition to its portfolio of ultrasound solutions.
• In October 2024, Medtronic plc announced that it had received approval from the United States Food and Drug Administration (FDA) for the Affera Mapping and Ablation System with Sphere-9 Catheter. The catheter is an all-in-one, high-density mapping and pulsed field and radiofrequency ablation catheter for treatment of persistent atrial fibrillation and for RF ablation of cavotricuspid isthmus-dependent atrial flutter.